Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
The Lancet (British edition), 2008-08, Vol.372 (9638), p.547-553 [Peer Reviewed Journal]Elsevier Ltd ;2008 Elsevier Ltd ;Copyright Elsevier Limited Aug 16-Aug 22, 2008 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(08)61236-2 ;PMID: 18707986 ;CODEN: LANCAO
Full text available